Opportunities for Impact: Building & Investing in Digital Platforms for Mental & Behavioral Health, Chronic Disease, & More | LSI Europe '23

Imran is a biotech and healthtech venture capital investor at LifeArc Ventures. He is responsible for both leading new investments and managing existing portfolio companies.

Imran is a former surgeon, digital health entrepreneur, and corporate development professional. He has been integral to over $1.5bn venture, licensing, and M&A deals at digital health, med tech and biopharma companies.

Imran received his medical degree from Imperial College London, where he graduated with joint honours from the Imperial College Business School and is a member of the Royal College of Surgeons.

He is committed to using his experiences to advance innovation to support the delivery of higher quality care and improve clinical outcomes.

Heather joined Oxford Science Enterprises in March 2022, a highly experienced venture capitalist, with over 20 years investment and company building experience.

At OSE, she leads the Health Tech team to identify new opportunities, catalyse the creation of transformational new businesses, and scale up the existing portfolio, covering digital health, diagnostics and medical devices.

Heather started her career in operational roles, creating new healthcare-related businesses and spin-outs for Unilever. She transitioned to investing while at Unilever, and subsequently spent the next 15 years in venture capital, more recently with J&J, leading J&J’s consumer Health Tech investment and partnering across EMEA.

She joined OSE from Optum Ventures where she was a Partner, responsible for establishing and leading the Global Health Tech investment fund on behalf of Optum, a leading technology-enabled US health services business, part of UnitedHealth Group.

Heather holds a PhD in Clinical Biochemistry from Queen’s University of Belfast.

Entrepreneurial-minded executive with over 10 years of increased responsibilities in key management positions in Business Development and Strategy in Europe, USA, Middle East and Africa. As a hard-worker and proven business leader, with both an analytical and strategic mindset and with multi-functional business capabilities, has consistently met or exceeded sales and profits targets by adopting innovative strategies.

Partner at Asabys, where he joined in 2018. Guillem is primarily responsible for sourcing, executing, and managing investments, with a major focus in the firm’s health-tech portfolio. He is also leading Asabys’ deal structuring, transactions and negotiations. Guillem currently serves on the board of directors of Amelia Virtual Care and Cara Care, and is an observer on the boards of Koa Health and Sidekick Health.

Prior to joining Asabys, Guillem was the Portfolio Manager of the Life Sciences portfolio at Caixa Capital Risc for four years. Before that, he served at EY within the Transaction Advisory Services primarily focusing on PE and VC transactions.

Guillem holds a BBA with a major in finance from Universitat Pompeu Fabra (UPF)